Clinical Trials Sponsored by Fundación Huésped

Total 2273 results

Fundación Huésped
Abbott

Completed

Induction-maintenance of Lopinavir/r in HIV-infected Subjects

HIV Infections

Canada, Argentina, Mexico
Fundación Huésped
Pfizer

Unknown

Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients (TERCETO)

AIDS | HIV-1 Adults Patients | Triple Class Failure

Argentina
Fundación Huésped
ViiV Healthcare

Completed

Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study (PADDLE)

HIV-1 Infection

Argentina
Fundación Huésped
ViiV Healthcare

Completed

Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women (TRANSViiV)

HIV Infections

Argentina
Pedro Cahn
Abbott

Completed

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects. (GARDEL)

HIV Infection

Argentina
Pedro Cahn
ViiV Healthcare

Withdrawn

Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study (PADDLE184V)

HIV-1 Infection

Argentina
Fundación Huésped
Dalhousie University; CanSino Biologics Inc.

Active, not recruiting

Phase IIB Study of Recombinant Novel Coronavirus Vaccine (FH-63)

COVID-19 Vaccine

Argentina
Fundación Huésped
ViiV Healthcare; Federal University of Bahia

Recruiting

Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 (DOLCE)

HIV-1-infection

Brazil, Argentina
Pedro Cahn
Merck Sharp & Dohme LLC

Unknown

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients (ARTE)

Chronic Infection With HIV

Argentina
Pedro Cahn
Merck Sharp & Dohme LLC

Terminated

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

HIV Infections

Argentina
Fundación Huésped
CanSino Biologics Inc.; Canadian Center for Vaccinology; Hospital Fernandez

Recruiting

Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older. (COVID-19)

Covid19

Argentina
Fundación Huésped
Ministerio de Salud de Ciudad Autónoma de Buenos Aires; Laboratorios Roemmers...

Recruiting

Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts (PENTZ)

Covid19 | SARS-CoV-2 Infection | Households Contacts

Argentina
Fundación Huésped
Ministry of Science and Technology,Argentine; National AIDS and STD programme... and other collaborators

Completed

Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects (ANDES)

HIV-1 Infection

Argentina
University of Miami
National Institute of Mental Health (NIMH); Fundacion Huesped, Buenos Aires... and other collaborators

Completed

Positive Connections: COPA2

Human Immunodeficiency Virus

Argentina
Laboratorio Elea Phoenix S.A.
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Completed

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

COVID-19 Virus Infection

Argentina
Fundación GECP

Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy (MERIT-lung)

Non-small Cell Lung Cancer Stage III | KRAS P.G12C

Spain
Fundación EPIC

Recruiting

Essential Pro PMCF Study ( rEPIC04E ) (rEPIC04E)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación GECP

Recruiting

Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases (NIVIPI-Brain)

Lung Cancer | Non Small Cell Lung Cancer | Brain Metastases, Adult

Spain
Fundación GECP

Recruiting

Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma (BIMES)

Mesothelioma; Lung

Spain
Fundación EPIC

Recruiting

ANGiographic Evaluation of Left Main Coronary Artery INtErvention (ANGELINE)

Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery Stenosis

Spain
Fundación GECP

Recruiting

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Non Small Cell Lung Cancer | EGFR Gene Mutation

Spain
Fundación EPIC

Active, not recruiting

Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR (iLITRO)

Coronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, Coronary

Spain
Fundación EPIC

Completed

NAVISCORE PMCF Study ( rEPIC04F ) (rEPIC04F)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación GECP

Active, not recruiting

New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy (NADIM-ADJUVANT)

Non-Small Cell Lung Cancer | Adjuvant Chemotherapy

Spain
Fundación EPIC

Completed

Laser-excimer Versus High-pressure Dilation to Treat Under-expansion of the Stent (LASER EXPAND)

Cardiovascular Diseases | Arterial Disease

Spain
Fundación GECP

Active, not recruiting

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients (CUBIK)

NSCLC | Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB

Spain
Fundación EPIC

Completed

Xperience Pro PMCF Study (rEPIC04A)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación Campbell

Completed

Medial Tab Flap for Soft Tissue Defects of the Leg

Leg Coverage Defects

Colombia
Fundación EPIC

Active, not recruiting

Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile (Monitor- ACS)

Heart Diseases | Atrial Fibrillation | Arrhythmias, Cardiac | Syncope | Tachycardia

Spain
Fundación GECP

Completed

Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients (VAC-CaP)

Covid19 | Lung Cancer

Spain
Fundación EPIC

Active, not recruiting

Registry of Coronary Lithotripsy in Spain. (REPLICA)

Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Arteriosclerosis | Arterial Occlusive Diseases

Spain
Fundación GECP

Completed

Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive (OSIREX)

Non Small Cell Lung Cancer

Spain
Fundación EPIC

Active, not recruiting

PRospective Evaluation Complementing Investigation With Acurate Neo Device (PRECISA)

Aortic Stenosis

Spain
Fundación Senefro

Completed

Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations (ACERCA)

ANEMIA

Spain
Fundación EPIC

Recruiting

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

Coronary Artery Disease

Spain
Fundación EPIC

Recruiting

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Aortic Valve Stenosis | Structural Valve Deterioration

Spain
Fundación GECP

Recruiting

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors (DUMAS)

NSCLC | Pancoast Tumor

Spain
Fundación GECP

Recruiting

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer (PEERS)

Small Cell Lung Cancer Extensive Stage

Spain
Fundación GECP

Recruiting

Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment (REAL-NADIM)

Neoadjuvant Treatment | Non Small Cell Lung Cancer Stage III

Spain
Fundación EPIC

Recruiting

ANGIOLITE PMCF Study ( rEPIC04F ) (rEPIC04F)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

CAPTURER PMCF Study ( rEPIC04D ) (rEPIC04D)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación GECP

Recruiting

Pathological Response After Neoadjuvant Treatment on NSCLC (PLANET)

Stage IIIA Non-small Cell Lung Cancer

Spain
Fundación IVI

Recruiting

Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy) (hSCU-PRP)

Asherman Syndrome | Endometrial Atrophy

Spain
Fundación IVI

Recruiting

Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF

DNA Damage | IVF | Oligospermia | ICSI | Embryo

Spain
Fundación GECP

Recruiting

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) (APOLO)

Lung Diseases | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Carcinoma Bronchiogenic Stage III

Spain
Fundación EPIC

Recruiting

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction

Spain
Fundación EPIC

Recruiting

Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm) (RETO 320)

Coronary Artery Disease

Spain
Fundación IVI

Recruiting

Use of PRP in Endometrial Reconstruction

Asherman Syndrome | Endometrial Atrophy

Spain
Fundación GECP

Active, not recruiting

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients (TELMA)

Non Small Cell Lung Cancer

Spain
Fundación EPIC

Active, not recruiting

A Prospective Study, Single-arm, Multicentre, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions. (TANSEI)

Coronary Artery Disease | Ischemic Heart Disease

Spain

Clinical Trials Sponsored by Fundación Huésped

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations